Tech Company Financing Transactions
Fathom Therapeutics Funding Round
Sutter Hill Ventures, Alexandria Venture Investments and Chemistry Ventures participated in a $47 million Series A funding round for Fathom Therapeutics. The round was recorded on 4/27/2026.
Transaction Overview
Company Name
Announced On
4/27/2026
Transaction Type
Venture Equity
Amount
$47,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the scaling of its lab-in-the-loop capabilities and the expansion of internal discovery programs in high-impact diseases.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
420 Lexington Avenue
New York, NY 10017
USA
New York, NY 10017
USA
Phone
Undisclosed
Website
Email Address
Overview
We use quantum chemistry and AI to design novel drug molecules by predicting their behavior inside living cells. Reach out to learn more about our Microcosmos drug discovery engine!
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Huafeng Xu
Browse more venture capital transactions:
Prev: 4/25/2026: Cognition AI venture capital transaction
Next: 4/27/2026: QuoIntelligence venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs